Filing Flows › DarioHealth (DRIO) › Q4 2024
DarioHealth (DRIO) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 10, 2025
DarioHealth (DRIO) reported revenue of $7.6M for the fourth quarter 2024 (Q4 2024), +110% from a year earlier and +2% from the quarter before. Operating margin was -153.4%, net loss $9.6M (126.7% of revenue).
DarioHealth, Q4 2024: revenue $7.6M (+110% year over year), operating margin -153.4%, net loss $9.6M, operating cash flow −$6.7M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.6M | +2% | +110% |
| Operating profit | −$11.7M | — | — |
| Net earnings | −$9.6M | — | — |
| Operating cash flow | −$6.7M | — | — |
What changed
Revenue was $7.6M in Q4 2024, up 110% year over year and up 2% from the previous quarter. Services was the largest line at 76% of revenue.
Gross margin was 55.3%, up 51.6 points from a year earlier. Operating costs exceeded revenue by $11.7M, an operating margin of -153.4%. Operating expenses grew 11% against revenue growth of 110%. The fastest-growing cost line was Research & development (+26%). The quarter ended with a net loss of $9.6M, narrower than the previous quarter's $12.3M loss. Non-operating items added $2.2M, -23% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$6.7M. Non-cash charges added back $2.1M of depreciation and amortization and $2.6M of share-based compensation. Working capital and other items used $1.8M. Capital expenditures of $21K exceeded it, leaving free cash flow of −$6.8M.
Questions
What was DarioHealth's revenue in the fourth quarter 2024?
DarioHealth (DRIO) reported revenue of $7.6M for the fourth quarter 2024 (Q4 2024), +110% from a year earlier and +2% from the quarter before.
Was DarioHealth profitable in the fourth quarter 2024?
Operating loss was $11.7M (-153.4% of revenue) and net loss $9.6M.
Source: DarioHealth 10-K on SEC EDGAR.